4//SEC Filing
AVALON PHARMACEUTICALS INC 4
Accession 0001209191-06-053569
CIK 0001162192operating
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 6:08 PM ET
Size
6.2 KB
Accession
0001209191-06-053569
Insider Transaction Report
Form 4
Whitaker Raymond J
Director
Transactions
- Award
Common Stock
2006-10-02$2.57/sh+2,675$6,875→ 7,571 total
Holdings
- 757,138(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Issued in lieu of cash payment of director fees pursuant to Company's Stock Election Policy for Non-employee Director Fees.
- [F2]Raymond J. Whitaker is a general partner of EuclidSR Partners, L.P. The reported securities are directly held by EuclidSR Partners, L.P. and EuclidSR Biotechnology Partners, L.P. The reporting person on this Form 4 disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
AVALON PHARMACEUTICALS INC
CIK 0001162192
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001162192
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 6:08 PM ET
- Size
- 6.2 KB